Flow Traders U.S.’s T. Rowe Price Health Care ETF TMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$814K Sell
23,827
-8,482
-26% -$262K 0.03% 485
2026
Q1
$935K Buy
32,309
+9,121
+39% +$270K 0.03% 469
2025
Q4
$689K Sell
23,188
-24,008
-51% -$697K 0.02% 488
2025
Q3
$1.26M Buy
+47,196
New +$1.19M 0.05% 352

Other funds holding TMED

Flow Traders U.S.'s TMED Position: Q2 2026 in Review

Flow Traders U.S. reduced its T. Rowe Price Health Care ETF (TMED) stake by 26% in Q2 2026, selling an estimated $262K and leaving 23,827 shares worth $814K. The position accounts for 0.03% of the portfolio, ranked #485.

Flow Traders U.S. first reported a position in TMED in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.26M in Q3 2025. 4 funds tracked by Wall St. Rank hold TMED as of Q2 2026.

  • Flow Traders U.S. held 23,827 shares of T. Rowe Price Health Care ETF worth $814K as of Q2 2026.
  • Flow Traders U.S. sold 8,482 T. Rowe Price Health Care ETF shares in Q2 2026, an estimated $262K.
  • T. Rowe Price Health Care ETF made up 0.03% of Flow Traders U.S.'s portfolio in Q2 2026, its #485 holding.
  • Flow Traders U.S. first reported a position in T. Rowe Price Health Care ETF in Q3 2025 and has held it in 4 quarters since.
  • Flow Traders U.S.'s T. Rowe Price Health Care ETF position peaked at $1.26M in Q3 2025.
  • 4 funds tracked by Wall St. Rank held T. Rowe Price Health Care ETF as of Q2 2026.

Based on Flow Traders U.S.'s 13F filing for Q2 2026, filed 14 Aug 2026.